메뉴 건너뛰기




Volumn 3, Issue 8, 2003, Pages 1169-1176

Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma

Author keywords

Chronic viral hepatitis; Combination therapy with thymosin 1; Hepatocellular carcinoma

Indexed keywords

AMANTADINE; FAMCICLOVIR; INTERFERON; LAMIVUDINE; PEGINTERFERON ALPHA2A; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; THYMOSIN ALPHA1;

EID: 0038342434     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00012-2     Document Type: Conference Paper
Times cited : (25)

References (45)
  • 2
    • 0035154469 scopus 로고    scopus 로고
    • Hepatitis B - An important public health issue
    • Maddrey W.C. Hepatitis B - an important public health issue. Clin. Lab. 47(1-2):2001;51-55.
    • (2001) Clin. Lab. , vol.47 , Issue.1-2 , pp. 51-55
    • Maddrey, W.C.1
  • 4
    • 0037099610 scopus 로고    scopus 로고
    • Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method
    • Iizuka N., Oka M., Yamada-Okabe H., Mori N., Tamesa T., Okada T.et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 15;62(14):2002;3939-3944.
    • (2002) Cancer Res. , vol.62 , Issue.14 , pp. 3939-3944
    • Iizuka, N.1    Oka, M.2    Yamada-Okabe, H.3    Mori, N.4    Tamesa, T.5    Okada, T.6
  • 5
    • 0027378724 scopus 로고
    • Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B
    • Wong D.K.H., Cheung A.M., O'Rourke K., Naylor C.D., Detsky A.S., Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. Ann. Intern. Med. 119:1993;312-323.
    • (1993) Ann. Intern. Med. , vol.119 , pp. 312-323
    • Wong, D.K.H.1    Cheung, A.M.2    O'Rourke, K.3    Naylor, C.D.4    Detsky, A.S.5    Heathcote, J.6
  • 6
    • 0036274159 scopus 로고    scopus 로고
    • Recent progress and new trends in the treatment of hepatitis B
    • Alberti A., Brunetto M.R., Colombo M., Craxi A. Recent progress and new trends in the treatment of hepatitis B. J. Med. Virol. 67(3):2002;458-462.
    • (2002) J. Med. Virol. , vol.67 , Issue.3 , pp. 458-462
    • Alberti, A.1    Brunetto, M.R.2    Colombo, M.3    Craxi, A.4
  • 7
    • 0036314982 scopus 로고    scopus 로고
    • Nucleoside analogues for chronic hepatitis B: Antiviral efficacy and viral resistance
    • Papatheodoridis G.V., Dimou E., Papadimitropoulos V. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. Am. J. Gastroenterol. 97(7):2002;1618-1628.
    • (2002) Am. J. Gastroenterol. , vol.97 , Issue.7 , pp. 1618-1628
    • Papatheodoridis, G.V.1    Dimou, E.2    Papadimitropoulos, V.3
  • 8
    • 0034769082 scopus 로고    scopus 로고
    • Interleukin-12 in the treatment of chronic hepatitis B and C
    • Zeuzem S., Carreno V. Interleukin-12 in the treatment of chronic hepatitis B and C. Antivir. Res. 52(2):2001;181-188.
    • (2001) Antivir. Res. , vol.52 , Issue.2 , pp. 181-188
    • Zeuzem, S.1    Carreno, V.2
  • 9
    • 0033552455 scopus 로고    scopus 로고
    • Chronic hepatitis B: New therapies on the horizon?
    • Pianko S., Mc Hutchinson J. Chronic hepatitis B: new therapies on the horizon? Lancet. 354:1999;1662-1663.
    • (1999) Lancet , vol.354 , pp. 1662-1663
    • Pianko, S.1    Mc Hutchinson, J.2
  • 10
    • 17744383748 scopus 로고    scopus 로고
    • Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
    • Boni C., Penna A., Ogg G.S., Bertoletti A., Pilli M., Cavallo C.et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology. 33(4):2001;963-971.
    • (2001) Hepatology , vol.33 , Issue.4 , pp. 963-971
    • Boni, C.1    Penna, A.2    Ogg, G.S.3    Bertoletti, A.4    Pilli, M.5    Cavallo, C.6
  • 11
    • 0035525235 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis B
    • Yuen M.F., Lai C.L. Treatment of chronic hepatitis B. Lancet, Infect. Dis. 1(4):2001 (Nov.);232-241.
    • (2001) Lancet, Infect. Dis. , vol.1 , Issue.4 , pp. 232-241
    • Yuen, M.F.1    Lai, C.L.2
  • 12
    • 0036096740 scopus 로고    scopus 로고
    • Management of patients with chronic hepatitis B
    • Liaw Y.F.J. Management of patients with chronic hepatitis B. Gastroenterol. Hepatol. 17(4):2002;406-408.
    • (2002) Gastroenterol. Hepatol. , vol.17 , Issue.4 , pp. 406-408
    • Liaw, Y.F.J.1
  • 13
    • 0036173630 scopus 로고    scopus 로고
    • Evolving therapies for the treatment of chronic hepatitis B virus infection
    • Locarnini S.A., Bartholomeusz A., Delaney W.E. Evolving therapies for the treatment of chronic hepatitis B virus infection. Expert Opin. Investig. Drugs. 11(2):2002;169-187.
    • (2002) Expert Opin. Investig. Drugs , vol.11 , Issue.2 , pp. 169-187
    • Locarnini, S.A.1    Bartholomeusz, A.2    Delaney, W.E.3
  • 14
    • 0030179606 scopus 로고    scopus 로고
    • Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B
    • Rasi G., Mutchnick M.G., Di Virgilio D., Sinibaldi-Vallebona P., Pierimarchi P., Colella F.et al. Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B. J. Viral Hepat. 3(4):1996;191-196.
    • (1996) J. Viral Hepat. , vol.3 , Issue.4 , pp. 191-196
    • Rasi, G.1    Mutchnick, M.G.2    Di Virgilio, D.3    Sinibaldi-Vallebona, P.4    Pierimarchi, P.5    Colella, F.6
  • 15
    • 0036633685 scopus 로고    scopus 로고
    • Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase
    • Lau G.K., Nanji A., Hou J., Fong D.Y., Au W.S., Yuen S.T.et al. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. J. Viral Hepat. 9(4):2002;280-287.
    • (2002) J. Viral Hepat. , vol.9 , Issue.4 , pp. 280-287
    • Lau, G.K.1    Nanji, A.2    Hou, J.3    Fong, D.Y.4    Au, W.S.5    Yuen, S.T.6
  • 16
    • 0034596944 scopus 로고    scopus 로고
    • Natural killer T cell activation inhibits hepatitis B virus replication in vivo
    • Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192(7):2000;921-930.
    • (2000) J. Exp. Med. , vol.192 , Issue.7 , pp. 921-930
    • Kakimi, K.1    Guidotti, L.G.2    Koezuka, Y.3    Chisari, F.V.4
  • 17
    • 0036461318 scopus 로고    scopus 로고
    • Immunology of hepatitis B infection
    • Jung M.C., Pape G.R. Immunology of hepatitis B infection. Lancet Infect. Dis. 2(1):2002;43-50.
    • (2002) Lancet Infect. Dis. , vol.2 , Issue.1 , pp. 43-50
    • Jung, M.C.1    Pape, G.R.2
  • 18
    • 0036271116 scopus 로고    scopus 로고
    • Viral determinants and host immune responses in the pathogenesis of HBV infection
    • Rapicetta M., Ferrari C., Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J. Med. Virol. 67(3):2002;454-457.
    • (2002) J. Med. Virol. , vol.67 , Issue.3 , pp. 454-457
    • Rapicetta, M.1    Ferrari, C.2    Levrero, M.3
  • 19
    • 0037080116 scopus 로고    scopus 로고
    • Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice
    • Gotsman I., Alper R., Klein A., Rabbani E., Engelhardt D., Ilan Y. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer. 15; 94(2):2002;406-414.
    • (2002) Cancer , vol.94 , Issue.2 , pp. 406-414
    • Gotsman, I.1    Alper, R.2    Klein, A.3    Rabbani, E.4    Engelhardt, D.5    Ilan, Y.6
  • 20
    • 0036131962 scopus 로고    scopus 로고
    • Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice
    • Gotsman I., Israeli D., Alper R., Rabbani E., Engelhardt D., Ilan Y. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice. Int. J. Cancer. 97(1):2002;52-57.
    • (2002) Int. J. Cancer , vol.97 , Issue.1 , pp. 52-57
    • Gotsman, I.1    Israeli, D.2    Alper, R.3    Rabbani, E.4    Engelhardt, D.5    Ilan, Y.6
  • 23
    • 0031888375 scopus 로고    scopus 로고
    • Gasbarrini Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: A preliminary experience
    • Stefanini G.F., Foschi F.G., Castelli E., Marsigli L., Biselli M., Mucci F.et al. Gasbarrini Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a preliminary experience. G. Hepatogastroenterol. 45(19):1998;209-215.
    • (1998) G. Hepatogastroenterol. , vol.45 , Issue.19 , pp. 209-215
    • Stefanini, G.F.1    Foschi, F.G.2    Castelli, E.3    Marsigli, L.4    Biselli, M.5    Mucci, F.6
  • 24
    • 0038581511 scopus 로고    scopus 로고
    • Thr Royal College of Physicians of London and the British Society of Gastroenterology. Clinical guidelines on the management of hepatitis C
    • Booth J.C., O'Grady J., Neuberger J. Thr Royal College of Physicians of London and the British Society of Gastroenterology. Clinical guidelines on the management of hepatitis C. Gut. 49(Suppl 1):2001;11-21.
    • (2001) Gut , vol.49 , Issue.SUPPL. 1 , pp. 11-21
    • Booth, J.C.1    O'Grady, J.2    Neuberger, J.3
  • 26
    • 0029833829 scopus 로고    scopus 로고
    • Meta-analysis of Interferon randomised trials in the treatment of viral hepatitis C: Effects of dose and duration
    • Poynard T., Leroy V., Cohard M., Thevenot T., Mathurin P., Opolon P.et al. Meta-analysis of Interferon randomised trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology. 24:1996;778-789.
    • (1996) Hepatology , vol.24 , pp. 778-789
    • Poynard, T.1    Leroy, V.2    Cohard, M.3    Thevenot, T.4    Mathurin, P.5    Opolon, P.6
  • 27
    • 0025847155 scopus 로고    scopus 로고
    • Ribavirin treatment for chronic hepatitis C
    • [1991]
    • Reichard O., Andersson J., Schvarcz R., Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet. 337:1999;1058-1061. [1991].
    • (1999) Lancet , vol.337 , pp. 1058-1061
    • Reichard, O.1    Andersson, J.2    Schvarcz, R.3    Weiland, O.4
  • 29
    • 0028825313 scopus 로고
    • Ribavirin as monotherapy for chronic hepatitis C: A randomised, double-blind, placebo-controlled trial
    • Di Bisceglie A., Conjeevaram H., Fried M., Sallie R., Park Y., Yurdayin C.et al. Ribavirin as monotherapy for chronic hepatitis C: a randomised, double-blind, placebo-controlled trial. Ann. Intern. Med. 123:1995;897-903.
    • (1995) Ann. Intern. Med. , vol.123 , pp. 897-903
    • Di Bisceglie, A.1    Conjeevaram, H.2    Fried, M.3    Sallie, R.4    Park, Y.5    Yurdayin, C.6
  • 30
    • 10344259671 scopus 로고    scopus 로고
    • Ribavirin treatment for patients with chronic hepatitis C: Results of a placebo-controlled study
    • Dusheiko G., Main J., Thomas H., Reichard O., Lee C., Dhillon A.et al. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J. Hepatol. 25:1996;591-598.
    • (1996) J. Hepatol. , vol.25 , pp. 591-598
    • Dusheiko, G.1    Main, J.2    Thomas, H.3    Reichard, O.4    Lee, C.5    Dhillon, A.6
  • 31
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. International Hepatitis Interventional Therapy Group [IHIT]
    • Poynard T., Marcellin P., Lee S., Niederau C., Minuk G., Bain V.et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. International Hepatitis Interventional Therapy Group [IHIT]. Lancet. 352:1998;1426-1432.
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.3    Niederau, C.4    Minuk, G.5    Bain, V.6
  • 32
    • 0032547938 scopus 로고    scopus 로고
    • Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
    • McHutchison J., Gordon S., Schiff E., Shiffman M., Lee W., Rustgi V.et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. New Engl. J. Med. 339:1998;1485-1492.
    • (1998) New Engl. J. Med. , vol.339 , pp. 1485-1492
    • McHutchison, J.1    Gordon, S.2    Schiff, E.3    Shiffman, M.4    Lee, W.5    Rustgi, V.6
  • 34
    • 0031752774 scopus 로고    scopus 로고
    • Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: Preliminary results
    • Moscarella S., Buzzelli G., Romanelli R.G., Monti M., Giannini C., Careccia G.et al. Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results. Liver. 18(5):1998;366-369.
    • (1998) Liver , vol.18 , Issue.5 , pp. 366-369
    • Moscarella, S.1    Buzzelli, G.2    Romanelli, R.G.3    Monti, M.4    Giannini, C.5    Careccia, G.6
  • 35
    • 17344368726 scopus 로고    scopus 로고
    • Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial
    • Sherman K.E., Sjogren M., Creager R.L., Damiano M.A., Freeman S., Lewey S., Davis D., Root S., Weber F.L., Ishak K.G., Goodman Z.D. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. Hepatology. 27(4):1998;1128-1135.
    • (1998) Hepatology , vol.27 , Issue.4 , pp. 1128-1135
    • Sherman, K.E.1    Sjogren, M.2    Creager, R.L.3    Damiano, M.A.4    Freeman, S.5    Lewey, S.6    Davis, D.7    Root, S.8    Weber, F.L.9    Ishak, K.G.10    Goodman, Z.D.11
  • 36
    • 0001623914 scopus 로고    scopus 로고
    • Interferon plus thymosin α-1 treatment of chronic hepatitis C infection: A meta-analysis
    • R. Schinazi, J. Sommadossi, & H. Thomas. London: International Medical Press
    • Sherman K., Sherman S. Interferon plus thymosin α-1 treatment of chronic hepatitis C infection: a meta-analysis. Schinazi R., Sommadossi J., Thomas H. Therapies for viral hepatitis. 1998;379-383 International Medical Press, London.
    • (1998) Therapies for viral hepatitis , pp. 379-383
    • Sherman, K.1    Sherman, S.2
  • 37
    • 0035016143 scopus 로고    scopus 로고
    • Cytokines and chemokines in the immune response to hepatitis C infection
    • Heydtmann M., Shields P., McCaughan G., Adams D. Cytokines and chemokines in the immune response to hepatitis C infection. Curr Opin Infect Dis. 14(3):2001;279-287.
    • (2001) Curr Opin Infect Dis , vol.14 , Issue.3 , pp. 279-287
    • Heydtmann, M.1    Shields, P.2    McCaughan, G.3    Adams, D.4
  • 38
    • 0036237490 scopus 로고    scopus 로고
    • Abnormal priming of CD4[+] T cells by dendritic cells expressing hepatitis C virus core and E1 proteins
    • [2001]
    • Sarobe P., Lasarte J.J., Casares N., Lopez-Diaz de Cerio A., Baixeras E., Labarga P.et al. Abnormal priming of CD4[+] T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J. Virol. 76(10):2002;5062-5070. [2001].
    • (2002) J. Virol. , vol.76 , Issue.10 , pp. 5062-5070
    • Sarobe, P.1    Lasarte, J.J.2    Casares, N.3    Lopez-Diaz de Cerio, A.4    Baixeras, E.5    Labarga, P.6
  • 39
    • 0037033359 scopus 로고    scopus 로고
    • Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein
    • Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U.et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 7;195(1):2002;35-41.
    • (2002) J. Exp. Med. , vol.195 , Issue.1 , pp. 35-41
    • Crotta, S.1    Stilla, A.2    Wack, A.3    D'Andrea, A.4    Nuti, S.5    D'Oro, U.6
  • 40
    • 0036139684 scopus 로고    scopus 로고
    • Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages
    • Rosen H.R., Miner C., Sasaki A.W., Lewinsohn D.M., Conrad A.J., Bakke A.et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology. 35(1):2002;190-198.
    • (2002) Hepatology , vol.35 , Issue.1 , pp. 190-198
    • Rosen, H.R.1    Miner, C.2    Sasaki, A.W.3    Lewinsohn, D.M.4    Conrad, A.J.5    Bakke, A.6
  • 42
    • 0036250072 scopus 로고    scopus 로고
    • Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-alpha/ribavirin
    • Amati L., Caradonna L., Magrone T., Mastronardi M.L., Cuppone R., Cozzolongo R.et al. Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-alpha/ribavirin. Curr. Pharm. Des. 8(11):2002;981-993.
    • (2002) Curr. Pharm. Des. , vol.8 , Issue.11 , pp. 981-993
    • Amati, L.1    Caradonna, L.2    Magrone, T.3    Mastronardi, M.L.4    Cuppone, R.5    Cozzolongo, R.6
  • 43
    • 0037086525 scopus 로고    scopus 로고
    • CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons
    • MacDonald A.J., Duffy M., Brady M.T., McKiernan S., Hall W., Hegarty J.et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 15;185(6):2002;720-727.
    • (2002) J. Infect. Dis. , vol.185 , Issue.6 , pp. 720-727
    • MacDonald, A.J.1    Duffy, M.2    Brady, M.T.3    McKiernan, S.4    Hall, W.5    Hegarty, J.6
  • 44
    • 0034982919 scopus 로고    scopus 로고
    • In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
    • Andreone P., Cursaro C., Gramenzi A., Margotti M., Ferri E., Talarico S.et al. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. J. Viral Hepatitis. 8(3):2001;194-201.
    • (2001) J. Viral Hepatitis , vol.8 , Issue.3 , pp. 194-201
    • Andreone, P.1    Cursaro, C.2    Gramenzi, A.3    Margotti, M.4    Ferri, E.5    Talarico, S.6
  • 45
    • 0038242780 scopus 로고    scopus 로고
    • Ameta-analysis of thymosin-A1 treatment in chronic hepatitis B virus (HBV) infection
    • Chan H. Ameta-analysis of thymosin-A1 treatment in chronic hepatitis B virus (HBV) infection. J. Hepatol. 34:2001;133.
    • (2001) J. Hepatol. , vol.34 , pp. 133
    • Chan, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.